News

Ideas That Generate Results

The continuous shifting focus of pharma majors towards preventive healthcare from curative healthcare has been boosting the sales of vaccines. Moreover, this growth is also supported by increasing prevalence of several chronic diseases worldwide. According to our new research study "Global Vaccine Market Forecast to 2012", global market for vaccine is projected to grow at a CAGR of around 13% during 2009-2012.

The report features extensive study on vaccine markets at regional level and has identified the US as the largest market for vaccines in the world. It also analyzes various factors that are pushing the growth of the vaccine market in these regions.

We have studied global vaccine market under various segments and found that at present, pediatric vaccines occupy the highest market share, but in future, rapid growth is expected in the adult vaccines' market, particularly in cancer and addiction segments. Cervical cancer vaccines are expected to lead this segment. The report analyzes these segments on the basis of their sub-segments and also provides some useful technical information which will prove beneficial to the client in understanding the market in a better way.

Our industry analysis observes that vaccine market for influenza, hepatitis B, HIV, and polio vaccines will grow at a healthy growth rate in future. The research study provides a complete rationale analysis for these segments as well. Besides this, several other vaccine markets, like malaria, meningitis, and tuberculosis have also been extensively covered in the report.

"Global Vaccine Market Forecast to 2012" also provides information of the key competitors in the market along with their business information and areas of expertise. The report shows a highly concentrated structure of the market, with the top four players dominating the market. Also, it provides valuable information on recent M&A activity in the sector. The report provides information on both domestic and international companies. This will provide our client a competitive edge over their competitors in the market.

For more information visit: http://www.rncos.com/Report/IM153.htm